Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1998
03/18/1998CN1176640A Inhibitors of microsomal triglyceride transfer protein and mothed
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176248A Restricted 9-CIS-retinoids
03/18/1998CN1176101A N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use
03/17/1998US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
03/17/1998US5728739 Ligands with affinity for retinoic acid receptors in synergistic combination with a fatty acid, treatment of diabetes, cardiovascular disease, atherosclerosis
03/17/1998US5728724 Treatment of postmenopause syndrome, osteoporosis, cardiovascular disorders and estrogen dependent cancer
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728685 Selectin receptors for inflammation modulators
03/17/1998US5728676 Use of insulin-like growth factors I and II for inhibition of inflammatory response
03/17/1998US5728564 U-PA mutants resistant to inhibition by their cognate inhibitors
03/17/1998US5728534 Screening assays involving effect of candidate agent on cell proliferation/activation and on expression of gene responsive to estrogen
03/17/1998CA1339760C Antihypertensive hyperimmine milk, prodiction, composition, and use
03/12/1998WO1998010090A1 Gata-6 transcription factor: compositions and methods
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009953A2 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998WO1998009949A1 Novel acetamide derivatives and protease inhibitors
03/12/1998WO1998009948A2 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009938A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009628A1 Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009619A1 Novel methods
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009519A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives
03/12/1998DE19636046A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten New carboxylic acid derivatives, their preparation and use as a mixed ET¶A¶ / ET¶B¶ receptor antagonists
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2265504A1 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998CA2264943A1 Novel methods
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264775A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264485A1 Gata-6 transcription factor: compositions and methods
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263250A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/12/1998CA2263198A1 Novel acetamide derivatives and protease inhibitors
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827408A1 Method of administration of igf-i
03/11/1998EP0827397A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/11/1998EP0705257B1 Aminoacid derivatives as no synthase inhibitors
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175574A Cycloalkano-pyridines
03/11/1998CN1175572A Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
03/11/1998CN1175439A Traditional Chinese medicine for treatment of chronic rheumatic heart disease
03/11/1998CN1175432A Gingko seed and ginseng capsule
03/11/1998CN1175414A Method for preparing substd. azacyclopyrimidine compound, its pharmaceutic salt or N-oxide
03/10/1998US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
03/10/1998US5726194 Endothelin receptor antagonists
03/10/1998US5726192 Platelet aggregation inhibiting compounds
03/10/1998US5726187 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
03/10/1998US5726175 Imidazo 1,2-A!indeno 1,2-E!pyrazine-2-carboxylic acid derivatives, preparation thereof and drugs containing same
03/10/1998US5726171 Antiarrhythmia agents
03/10/1998US5726168 Lipophilic benzothiophenes
03/10/1998US5726164 Nanosuspensions for intravenous administration
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/05/1998WO1998008965A2 Cd95 regulatory gene sequences and transcription factors
03/05/1998WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids
03/05/1998WO1998008855A2 N6 heterocyclic substituted adenosine derivatives
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008838A1 Substituted amine derivatives
03/05/1998WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008811A1 Cyclic amine derivatives
03/05/1998WO1998008538A1 Use of hyaluronidase
03/05/1998WO1998008531A1 Use of glp-1 or analogs in treatment of myocardial infarction
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
1 ... 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 ... 1595